Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Suzanne" (42)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Drospirenone and Ethinylestradiol (G03AA12) 42 products
WHO-DDD
DrugBank.ca
IP
CI
Dretine 21
21
k.A.
Coated tablets: 2 Active Agents
Future Health Pharma
GmbH
B
FB
G
IP
CI
Dretine 21
3 x 21
k.A.
Coated tablets: 2 Active Agents
Future Health Pharma
GmbH
B
FB
G
IP
CI
Dretinelle 21
21
k.A.
Coated tablets: 2 Active Agents
Future Health Pharma
GmbH
●
B
FB
G
IP
CI
Dretinelle 28
28
k.A.
Coated tablets: 2 Active Agents
Future Health Pharma
GmbH
●
B
FB
G
IP
CI
Dretinelle 21
3 x 21
k.A.
Coated tablets: 2 Active Agents
Future Health Pharma
GmbH
B
FB
G
IP
CI
Dretinelle 28
3 x 28
k.A.
Coated tablets: 2 Active Agents
Future Health Pharma
GmbH
B
FB
G
IP
CI
Eloine
28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Eloine
3 x 28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Eloine
6 x 28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Sue 20
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Sue 20
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Sue 20
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Sue 30
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Sue 30
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Sue 30
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Suzanne
28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Suzanne
3 x 28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Suzanne
6 x 28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Yira 20
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 20
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 20
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 30
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 30
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 30
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
Mirjanne 20
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 20
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 20
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 30
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 30
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 30
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Drospibel 20
21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20 Conti
28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20
3 x 21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20 Conti
3 x 28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20
6 x 21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20 Conti
6 x 28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30
21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30 Conti
28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30
3 x 21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30 Conti
3 x 28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30
6 x 21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30 Conti
6 x 28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
